Reversible nitrous oxide myelopathy and a polymorphism in the gene encoding 5,10-methylenetetrahydrofolate reductase

British Journal of Anaesthesia

Volumn 96, Issue 2, 2006, Pages 222-225

  Lacassie, H J ^a,b   Nazar, C ^a   Yonish, B ^c   Sandoval, P ^a   Muir, H A ^b   Mellado, P ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anaesthesia, inhalation; Anaesthetics gases, nitrous oxide; Complications, myelopathy; Enzymes, 5,10 methylenetetrahydrofolate reductase; Gene, MTHFR; Vitamins, folic acid

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ALANINE; ATRACURIUM; CYANOCOBALAMIN; CYSTEINE; ETOMIDATE; FENTANYL; FOLIC ACID; GENOMIC DNA; ISOFLURANE; ISOPROTEIN; METHYLPREDNISOLONE; NITROUS OXIDE; OXYGEN; THIOPENTAL; THREONINE; VALINE;

ADULT; ANESTHESIA INDUCTION; ARM DISEASE; ARTICLE; BLADDER OBSTRUCTION; CASE REPORT; CERVICAL MYELOPATHY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYANOCOBALAMIN DEFICIENCY; DEEP VEIN THROMBOSIS; DEMYELINATING DISEASE; DNA DETERMINATION; ELECTROMYOGRAPHY; ENDOTRACHEAL INTUBATION; EXON; EXPERIENCE; FOLLOW UP; GENE MUTATION; GENERAL ANESTHESIA; GENETIC ASSOCIATION; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HOMOZYGOSITY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERHOMOCYSTEINEMIA; INTERMITTENT CATHETERIZATION; INTERVERTEBRAL DISK HERNIA; LABORATORY TEST; LAMINECTOMY; LEG DISEASE; MACROCYTIC ANEMIA; MALE; NEUROGENIC BLADDER; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; PARAPLEGIA; PARESIS; PATIENT TRANSPORT; PHYSIOTHERAPY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSORY DYSFUNCTION; SEQUENCE ANALYSIS; VERTEBRAL CANAL STENOSIS; VITAMIN SUPPLEMENTATION;

EID: 31844442133     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aei300     Document Type: Article

References (15)

1. Kniffin CL. 5,10-Methylenetetrahydrofolate reductase; MTHFR. OMIM, 2002
2. Selzer RR, Rosenblatt DS, Laxova R, Hogan K. Adverse effect of nitrous oxide in a child with 5,10-methylenetetrahydrofolate reductase deficiency. N Engl J Med 2003; 349: 45-50
3. Sibani S, Christensen B, O'Ferrall E, et al. Characterization of six novel mutations in the methylenetetrahydrofolate reductase (MTHFR) gene in patients with homocystinuria. Hum Mutat 2000; 15: 280-7
4. Fakhrai-Rad H, Pourmand N, Ronaghi M. Pyrosequencing: An accurate detection platform for single nucleotide polymorphisms. Hum Mutat 2002; 19: 479-85
5. Rieder MJ, Livingston RJ, Daniels MR, et al. Homo sapiens 5,10-methylenetetrahydrofolate reductase (NADPH) (MTHFR) gene, complete cds.: NIEHS-SNPs, Environmental Genome Project, NIEHS ES15478. Department of Genome Sciences, Seattle, WA, USA, 2003
6. McKusick VA. Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity. OMIM, 1986
7. Kang SS, Wong PW, Susmano A, Sora J, Norusis M, Ruggie N. Thermolabile methylenetetrahydrofolate reductase: An inherited risk factor for coronary artery disease. Am J Hum Genet 1991; 48: 536-45
8. Wilcken B, Bamforth F, Li Z, et al. Geographical and ethnic variation of the 677C>T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide. J Med Genet 2003; 40: 619-25
9. McAndrew PE, Brandt JT, Pearl DK, Prior TW. The incidence of the gene for thermolabile methylene tetrahydrofolate reductase in African Americans. Thromb Res 1996; 83: 195-8
10. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-3
11. van der Put NM, Steegers-Theunissen RP, Frosst P, et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995; 346: 1070-1
12. Sohda S, Arinami T, Hamada H, Yamada N, Hamaguchi H, Kubo T. Methylenetetrahydrofolate reductase polymorphism and preeclampsia. J Med Genet 1997; 34: 525-6
13. den Heijer M, Koster T, Blom HJ, et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996; 334: 759-62
14. Stein JH, McBride PE. Hyperhomocysteinemia and atherosclerotic vascular disease: Pathophysiology, screening, and treatment. off. Arch Intern Med 1998; 158: 1301-6
15. Gudnason V, Stansbie D, Scott J, Bowron A, Nicaud V, Humphries S. C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR): Its frequency and impact on plasma homocysteine concentration in different European populations. EARS group. Atherosclerosis 1998; 136: 347-54